The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden.
 
Joshua K. Sabari
No Relationships to Disclose
 
Ricklie Ann Julian
No Relationships to Disclose
 
Ai Ni
No Relationships to Disclose
 
Darragh Halpenny
No Relationships to Disclose
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb
 
Alexander E. Drilon
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Genentech/Roche; Ignyta; Loxo; Pfizer; Takeda; TP Therapeutics
 
Bob T. Li
Consulting or Advisory Role - Biosceptre International; Guardant Health; Mersana; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); GRAIL (Inst); Illumina (Inst); Roche/Genentech (Inst)
 
John T. Poirier
No Relationships to Disclose
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Harpoon Therapeutics; Seagen
 
Natasha Rekhtman
No Relationships to Disclose